Haemophilus influenzae is an important cause of invasive disease. The infant rat is the accepted model of invasive H. influenzae disease. Here, we report the genome sequences of six nontypeable H. influenzae strains that establish bacteremia in the infant rat. 
aemophilus influenzae colonizes the human nasopharynx and is an opportunistic pathogen causing significant human disease. H. influenzae causes both mucosal and invasive infections, including otitis media, exacerbations of chronic obstructive pulmonary disease, and bacteremia (1) (2) (3) . Vaccines directed at the H. influenzae type b capsule have significantly reduced invasive disease caused by such strains (3), and the majority of H. influenzae invasive disease is now caused by nontypeable strains (1) . The infant rat is a widely used model of invasive H. influenzae disease (4, 5) . H. influenzae type b strains readily establish bacteremia and meningitis in this model when infected via either the intraperitoneal or nasopharyngeal route (6). However, nontypeable H. influenzae (NTHi) strains less reliably establish and maintain bacteremia in this model. We have previously used the sequenced blood isolate R2866 in the rat model (7) . An infective dose of 10 5 CFU R2866 reproducibly establishes durable bacteremia. However, in our hands, other well-characterized NTHi strains isolated from the nasopharynx (strain 86-028NP) and middle ear (strain R2846) do not establish bacteremia, even at infective doses up to 10 6 CFU. For ongoing studies on NTHi virulence we required additional strains able to establish bacteremia in the infant rat. We tested 14 NTHi isolates, all isolated from blood, CSF, or brain abscess, for their ability to establish bacteremia in the infant rat. Six strains were able to reproducibly establish bacteremia in the infant rat, while the rest were unable to do so regardless of dose.
We performed whole-genome sequencing on the six isolates that established bacteremia. NTHi samples were prepared using 50 ng of total genomic DNA according to Nextera DNA library kit protocols (Illumina, Inc). Samples were indexed according to standard protocols so that they could be pooled together and sequenced simultaneously in a single run on the Illumina MiSeq platform using paired-end 150-bp (strains HI1974, HI2114, and HI2116) or paired-end 250-bp (strains HI1980, HI1988, and HI2004) chemistry. Prior to sequencing, each library was run individually on the Agilent High Sensitivity DNA chip to confirm library quality and average insert size. Samples were pooled in equimolar amounts, and 8 pM of the pool was run on the sequencer. Per Illumina's recommendation, phiX control was spiked into the library pool prior to loading for quality control purposes. For the 300-cycle runs 5 to 10% phiX was used, and for the 500-cycle runs 1% phiX was used per Illumina protocols. A total of thirty to forty million reads were collected for each run. Raw sequence data were de novo assembled and aligned to a reference isolate using CLC Genomics Workbench (CLC Bio) to identify single-nucleotide polymorphisms as well as regions with insertions or deletions (indels). Sequencing results are summarized in Table 1 . The sequences reported herein will facilitate further in vivo studies of invasive NTHi disease and virulence determinants. Nucleotide sequence accession numbers. Genome sequences for the six strains described herein have been deposited in GenBank under the accession numbers listed in Table 1 .
